Histone deacetylase 3 (Hdac3) is the catalytic enzyme in a transcriptional repression complex that contains the nuclear hormone co-repressors (N-CoR or SMRT). 1, 2 As such, Hdac3 has largely been studied in the context of gene regulation of targets of nuclear hormone receptors and other transcription factors that recruit these corepressors. However, gene deletion studies in mice have shed new light on potential cell cycle roles of this histone deacetylase complex.
Because of the roles of nuclear hormone signaling pathways in metabolism, the physiological roles of Hdac3 and its activating factors NCOR and SMRT are of great interest. But just as important as its roles in metabolism, is the recruitment of this repression complex by oncogenic transcription factors such as BCL6. 3 In fact, Hdac3 may be a key target of Vorinostat and Romidepsin, two drugs approved by the FDA for use in cutaneous T-cell lymphoma. These roles in metabolism and cancer have spurred the genetic analysis of Hdac3 deficiency in mice. Deletion of Hdac3 in the germ line led to very early embryonic lethality. 4, 5 Surprisingly, when the Cre-loxP system was used to delete Hdac3 in mouse embryo fibroblasts (MEFs), apoptosis was induced with a delayed progression of cells through S phase and an increase in S phase-associated histone acetylation marks (H4K5ac and H4K12ac). Also, loss of Hdac3 triggered DNA damage, which required cell cycle progression, as no DNA damage was observed in Hdac3 -/-MEFs after serum starvation. Similar results were found after treatment with SAHA (Vorinostat), suggesting that the cell cycle-dependent DNA damage contributes to the therapeutic window of HDIs. Since the liver is enriched with nuclear hormone receptors that mediate gene activation and control metabolic pathways, we deleted Hdac3 specifically in the liver using Albumin-Cre. 6 Loss of Hdac3 caused a dramatic increase in the liver size with fat accumulation and disruption of a balance between carbohydrate and lipid metabolism. Gene expression analysis of Hdac3-null livers indicated that inactivation of Hdac3 triggered a significant upregulation of genes that regulate lipid and cholesterol biosynthesis in the liver. Many of these genes are controlled by nuclear hormone receptors that utilize NCoR and SMRT for transcriptional repression in the absence of the ligand including PPARγ. 6 Given the defects in cell cycle control and the changes in gene expression, we used the liver-specific knockout of Hdac3 to further explore the mechanistic basis for these defects. We found that both non-homologous (NHEJ) and homologous recombination (HR) DSB repair efficiency was significantly reduced in the absence of Hdac3. 7 This finding suggested that a common element, perhaps changes in chromatin structure, might be affected in the absence of Hdac3. Consistent with the results in MEFs, Hdac3-null livers showed increases in H4K5ac, H4K12ac and H3K9, K14ac. Even more dramatic changes in these marks were observed in Hdac3-null NIH3T3 cells synchronized in G 0 /G 1 , which suggested that these residues were not deacetylated in late-S phase following histone deposition. Consistent with the increase in H3K9ac, we noted a concomitant decrease in H3K9me3 (a heterochromatin mark) in Hdac3-null livers. Electron microscopy showed a loss of heterochromatin content in null hepatocytes.
Importantly, chromatin in Hdac3-null nuclei was more sensitive to micrococcal nuclease and histone H3 was readily solublized upon salt extraction, indicating altered histone-histone and histone-DNA interactions. Thus, global chromatin structure and higher-order packaging were affected in cells lacking Hdac3.
Given the requirement for Hdac3 in DNA repair, we examined the consequences of Hdac3 inactivation on chromosomes as they progress through mitosis. Analysis of metaphase spreads revealed an increase in breaks and gaps in Hdac3-null cells, indicating that Hdac3 is required for the maintenance of genome stability in vitro. Given that defects in DNA repair and chromatin structure cause various types of cancers, we aged Alb-Cre:Hdac3-null mice. These mice developed hepatocellular carcinoma with a mean survival of approximately 10 months. 7 Further analysis will test if the increased fat content and fatty liver disease is the cause of the HCC observed in the absence of Hdac3.
Genetic analysis of Hdac3 supports a critical role for the NCoR/SMRT:HDAC3 repression complex in transcriptional control, especially via nuclear hormone receptors. In addition, these studies revealed a cell cycle regulatory role for this complex. Inactivation of Hdac3 caused a two-to four-fold increase in global histone acetylation, which may be linked to Hdac3 functions in late S phase or G 2 /M, yet many details remain to be uncovered. Unlike HDAC1 and HDAC2, HDAC3 does not appear to be an integral component of histone chaperone complexes that deposit and deacetylate histones on newly synthesized DNA. As such, the role of Hdac3 in the cell cycle is still unanswered, including the factors that recruit Hdac3, its role in maintaining chromatin structures at the nucleosome level and its role in genomic stability.
